Indian API Market to Reach US$ 19.09 Billion by 2020

2026-07-07 10:07:45 Health and Fitness

574

The Indian APIs market was around US$9.3 Billion in 2014, and is anticipated to grow to around US$ 19.09 Billion by 2020, at a CAGR of around 13% during 2014-2020. It is believed that, the market will continue the trend of its incessant growth owing to factors, such as a rising number of blockbuster drugs expirations resulting in the growth of generics, inauguration of government schemes to promote generic drugs market in India, rapid drug discovery and development process, increasing demand for contract manufacturing, need to reduce API imports from China and stupendous rise in the pharmaceutical market.

According to our report, ?Opportunities in Indian API Market?, in the wake of the above developments the Indian API industry is expected to grow at a CAGR of around 13% from 2014-2020. The market segmentations have been mentioned. The domestic market and export scenario has also been highlighted. Various drivers and challenges affecting the API industry in India are listed. We have also deduced a list of top five countries which are ruling the API market of the world. These countries include the likes of US, Japan, Italy, China and India. The government initiatives and regulatory scenario pertaining to API manufacturing and trade has also been discussed in detail. A future opportunity assessment and recommendations have been highlighted to indicate that the Indian API industry has a promising future.

The report also covers the key players of the Indian API Market. For every player, a brief business overview, geographic revenue break up and segment wise revenue break up along with key financials has been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of the players. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian API market.

Some of the key findings of the report are:

- Patent Expiry of Blockbuster Drugs Driving Indian API Market
- Overdependence on China for API Imports- A Major Challenge

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM788.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.